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ABSTRAK
Latar belakang: Toll-like receptor (TLR) adalah reseptor pengenalan pola yang mengenali pola molekul 
terkait patogen dalam mikroorganisme. Makrofag mengenali adanya mikobakteri melalui Toll-Like Receptor 2 
(TLR2) dan penanda lanjutan pada produksi sitokin, proinflammatory TNF-α, IL-1β, IL-6, IL-12, IL-15, IL-18 
dan IFN-γ, serta anti-inflamasi IL4, IL-10 dan TGF-β. Polimorfisme gen TLR2 sangat ditentukan oleh etnisitas 
dan geografi, karenanya diperlukan analisis hubungan polimorfisme Arg753Gln dan Arg677Trp gen TLR2 
dengan kerentanan menderita TB paru aktif dan peranan beberapa sitokin pada populasi Indonesia di Bandung 
Jawa Barat. Metode: penelitian observasional analitik dengan rancangan potong lintang dilaksanakan pada 
periode April 2011–Mei 2012 di RS Dr. Hasan Sadikin Bandung. Populasi penelitian terdiri dari penderita TB 
paru aktif dengan BTA positif dan sebagai pembanding adalah TB laten. Adanya polimorfisme gen Arg753Gln 
dan Arg677Trp diperiksa dengan metode polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP). Kadar sitokin IFN-γ, TNF-α, IL-10, dan IL-12 juga dibandingkan antara kelompok TB aktif dan 
TB laten. Hasil: polimorfisme heterozigot Arg753Gln gen TLR2 ditemukan pada 9 dari 86 (10.5%) penderita TB 
paru aktif dan tidak ditemukan pada TB laten. Pada kedua kelompok tidak ditemukan polimorfisme Arg677Trp. 
Odds Ratio untuk polimorfisme Arg753Gln adalah 28,07 (p=0,022). Tidak ditemukan perbedaan bermakna kadar 
sitokin IFN-γ, TNF-α, IL-10, dan IL-12 antara penderita TB paru dengan polimorfisme Arg753Gln dan penderita 
TB paru tanpa polimorfisme tersebut. Kesimpulan: polimorfisme Arg753Gln gen TLR2 merupakan faktor risiko 
menderita TB paru pada populasi orang Indonesia di Bandung, sedangkan polimorfisme Arg677Trp gen TLR2 
bukan. Peningkatan risiko ini tidak terkait dengan perubahan kadar IFN-γ, TNF-α, IL-10 maupun IL-12.
Kata kunci: Toll-like receptor 2 (TLR2), Arg753Gln, Arg677Trp, sitokin, M. tuberculosis.
ABSTRACT
Background: Toll-like receptor is a pattern recognition receptor (PRR) that recognize pathogen-associated 
molecular pattern (PAMP) in a microorganism. Macrophages recognize the presence of mycobacteria through 
Toll-Like Receptor 2 (TLR2) and signaling further lead to the production of cytokines, both proinflammatory 
TNF-α, IL-1β, IL-6, IL-12, IL-15, IL-18 and IFN-γ, as well as anti-inflammatory IL4, IL-10 and TGF-β. TLR2 
gene polymorphism is strongly determined by ethnicity and geography. Therefore it is necessary to uncovered the 
existence and association between Arg753Gln and Arg677Trp TLR2 gene polymorphism with TB susceptibility and 
its underlying mechanisms in Indonesian population in Bandung West Java. Methods: analytical observational 
Arto Y. Soeroto                                                                                                               Acta Med Indones-Indones J Intern Med
54
study with cross-sectional design was conducted in Hasan Sadikin General Hospital Bandung from April 2011 
to May 2012. Study population consisted of active pulmonary TB patient with positive AFB smear and Latent TB 
to ascertain previous MTb exposure. Polymorphism of gen Arg753Gln and Arg677Trp gene was determined with 
polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods. Plasma levels of 
IFN-γ, TNF-α, IL-10 and IL-12 were also compared between active and latent TB group. Results: heterozygote 
Arg753Gln TLR2 gene polymorphism was found in 9 of 86 pulmonary TB subjects (10.5%) but none in the latent 
TB group. The Arg677Trp polymorphism was not found in both groups. The odds ratio for Arg753Gln existence 
was 28.07 (p=0.022). No differences in the levels of IFN-γ, TNF-α, IL-10 and IL-12 between active pulmonary 
TB and latent TB subjects with and without Arg753Gln TLR2 gene polymorphism. Conlusion: Arg753Gln 
polymorphism of TLR2 gene is a risk factor for active pulmonary TB while Arg677Trp polymorphism is not. 
The Increased risk is not mediated by the difference in IFN-γ, TNF-α, IL-10 and IL-12 serum levels.
Keywords: Toll-like receptor 2 (TLR2), Arg753Gln, Arg677Trp, cytokines, M. tuberculosis.
INTRODUCTION
Toll-like receptor is a pattern recognition 
receptor (PRR) that recognizes pathogen-
associated molecular pattern (PAMP) in a 
microorganism. Macrophages recognize the 
presence of mycobacteria through Toll-Like 
Receptor 2 (TLR2) and signaling further 
leading to the production of cytokines, both 
proinflammatory TNF-α, IL-1β, IL-6, IL-12, IL-
15, IL-18 and IFN-γ, as well as anti-inflammatory 
IL4, IL-10 and TGF-β. Macrophage activation 
occurs, followed by the killing of Mycobacterium 
tuberculosis (MTb) in the macrophage and 
activation of the adaptive immune system 
specific to MTb in the form of cell mediated 
immunity and delayed-type hypersensitivity.1-5
Toll Like Receptor 2 gene polymorphisms 
Arg753Gln decreases macrophage response 
against bacterial peptide thereby reducing the 
immune response of the host.6 Research in 
Turkey found the TLR2 gene polymorphism 
Arg753Gln in 17.9% of patients with tuberculosis 
(TB) and 7.7% in control and increased the 
risk of developing tuberculosis by 6.04 times 
in homozygous mutant and 1.60 times in 
heterozygous mutants.7 Jin et al.8 in China 
and Mishra et al.9 in India also found role of 
Arg753Gln heterozygous polymorphisms on 
susceptibility to tuberculosis.
Other TLR2 gene polymorphism Arg677Trp 
increase the vulnerability of leprosy and decreases 
production of IL-12.10 This polymorphism 
inhibit immune response to M. Leprae and 
MTb infection.11 Research in Tunisia in 2004 by 
Ben-Ali et al.12 found heterozygous form of this 
polymorphism in 94% of patients with TB and 
31% of controls.
TLR2 gene polymorphism is strongly 
determined by ethnicity and geography.13-16 
Therefore it is necessary to uncovered role of 
both TLR2 gene polymorphism above in TB in 
Indonesian population and subsequent cytokine 
levels alteration.
METHODS
An observational analytic study with cross-
sectional design was conducted at Hasan 
Sadikin General Hospital Bandung Indonesia. 
Ethical Clearance No 97/ FKUP-RSHS/KEPK/
Kep./EC/2011 was obtained from Health 
Research Ethics Commttee Faculty of Medicine 
Universitas Padjadjaran – dr. Hasan Sadikin 
Hospital, Bandung. Study was done between 
April 2011 to May 2012 in Outpatient and 
Inpatients Departement, Hasan Sadikin General 
Hospital. Study population were enrolled 
according to consecutive admission and after 
informed consent. Study population consist of 
active tuberculosis patients over 18 years old and 
latent TB with similar age and sex were choosen 
as control to ensure exposure to Mycobacterium 
tuberculosis in both groups. Active pulmonary 
TB was defined as TB patient with smear 
positive, while latent TB was defined as positive 
tuberculin test, with normal chest x-ray and no 
clinical symptom. Patients were excluded if 
having risk factors for TB such as HIV infections, 
diabetes mellitus, end stage renal disease, 
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silicosis, gastrectomy and jejunoileostomy, 
malignant diseases, post organ transplantation, 
pregnancy, sarcoidosis, acute infectious diseases, 
and current use of drugs that interfere immune 
system such as corticosteroids, cytostatic and 
malnutrition.
For DNA isolation, 300 uL of blood is fed 
into Eppendorf tube, 900 uL RBC lysis solution 
was added and incubated for 10 minutes at room 
temperature, centrifuged at 13,000-16,000 rpm 
for 20 seconds to obtain leukocyte pellet, and 
the supernatant was then discarded. Add 300 uL 
cell lysis on a tube containing leucocyte pellets. 
1.5 μL RNAse was added and incubated for 
5 min at 37° C. Protein precipitation solution 
of 100 μL was added, vortex 15 seconds later, 
centrifuged for 3 minutes and the supernatant 
transferred into new Eppendorf tube. Then, 600 
μl of isopropanol to supernatant was added to 
precipitate the DNA, mixed by turning the tube 
about 10 times, then centrifuged for one minute 
to get the DNA pellet and the supernatant was 
removed. The DNA pellets were washed using 
ethanol by adding 600 μL of cold ethanol. It 
was centrifuged to precipitate the DNA pellet, 
discard ethanol and dry by turning the tube over 
the tissue until ethanol evaporates. The pellet 
was then dissolved with 50 μL of TE buffer. The 
preparations were stored in a freezer (-20° C).
Arg677Trp, Arg753Gln polymorphisms of 
TLR2 gene were determined from leukocyte 
nucleus using polymerase chain reaction-
restriction fragment length polymorphism (PCR-
RFLP) methods at the Molecular Biology Lab 
Medical Research Unit Faculty of Medicine, 
Universitas Padjadjaran. After DNA was isolated, 
the next step was to determine the existence of 
Arg753Gln and Arg677Trp polymorphism 
of gene TLR2 by restriction fragment length 
polymorphism (RFLP) method. The restriction 
process was performed twice for each Arg753Gln 
polymorphism and Arg677Trp TLR2 gene.
For detect ion of  Arg677Trp (CGG 
>TGG), restriction enzym used was Mwol 
(GCNNNNNNNGC). Primers used were:
• Primer 677F: 5’CCCCTTCAAGTTGT 
GGCTTCATAAG 3’
• Primer 677R: 5’AGTCCAGTTCATACTT 
GCACCAC 3’
For detection of Arg753Gln (CGG >CAG), 
restriction enzym used was MSpl (CCGG) and 
Primers used were:
• Primer 753F: 5’CATTCCCCAGCGCTTCT 
GCAAGCTCC3’
• Primer 753R: 5’GGAACCTAGGACTTTAT 
CGCAGCTC3’
Cytokines was measured at Research and 
Esoteric Division of Clinical Lab Prodia Jakarta.
IFN-gamma examination using Human 
IFN-γ high sensitivity ELISA kit BMS228HS 
(eBioscience). TNF-α Examination were done 
using Quantikine HS ELISA catalog number 
HSTA00D for the quatitative determination of 
human tumor necrosis factor alpha (TNF-α) 
concentration in serum and plasma, IL-10 
examination were done using Quantikine 
catalog number HS100C for the quantitative 
determination of Human interleukine 10 IL-
10) concentration in serum and plasma. IL-12 
examination were done using Quantikine HS 
human IL-12 immunoassays catalog number 
HS120 for concentrations in cell culture 
supernatants, serum and plasma.
Sample size was determined based on 
formula for unpaired catagorical comparative 
analysis technique. From this formula, a 
minimum of 127 subjects in each group were 
needed for Arg753Gln polymorphism TLR2 
gene study, and for polymorphism Arg677Trp 
TLR2 gene 42 subjects were needed. Samples 
were collected from consecutive admission at 
Outpatient and Inpatient Department of dr. Hasan 
Sadikin General Hospital, Bandung, Indonesia.
Statistical Analysis
Analysis of differences in Arg753Gln and 
Arg677Trp polymorphism of TLR2 gene was 
conducted using Fisher’s exact test or Chi-
square. Analysis of differences in levels of 
cytokines with unpaired t-test or Mann-Whitney. 
Limit of statistical significance was set at p value 
of <0.05.
RESULTS
A total of  200 subjects consisted of  86 
active pulmonary TB smear-positive and 114 
subjects with latent TB were eligible and enrolled 
between April 2011 to May 2012. Characteristics 
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was no polymorphism Arg677Trp found in both 
groups (Table 2).
Fisher ’s exact test shows that there 
were significant differences in TLR2 gene 
polymorphism Arg753Gln groups between 
patients with active pulmonary TB and latent 
TB group (p<0.001) (Table 3).
Table 1. Characteristics of study population
Characteristic Active Pulmonary TB Latent TB
Age (years), median 
(min-max) 32 (18–70) 31 (18–70)
Gender, n (%)
 - Male 46 (53.5) 58 (50.9)
 - Female 40 (46.5) 56 (49.1)
BMI (kg/m2), mean 
(SD) 17.22 (2.83) 24.64 (4.147)
Complain, n (%)
 - Cough 79 (91.9) 0
 - Hemoptisis 18 (20.9) 0
 - Sputum Production 77 (89.5) 0
 - Shortness of 
Breath 55 (64.0) 0
 - Fever 62 (72.1) 0
 - Night Sweat 47 (54.7) 0
 - Wight Loss 72 (83.7) 0
TB history, n (%)
 - History of previous 
TB disease 27 (31.4) 8 (7.0)
 - TB contact
 - Yes 15 (17.558) 40 (35.1)
 - No 26 (30.2) 14 (12.3)
 - Not Sure 45 (52.3) 60 (52.6)
Table 2. Distribution of polymorphism Arg753Gln and Arg677Trp in active pulmonary TB and latent TB
Active Pulmonary TB (n = 86) Latent TB (n = 114)
753Gln 753Arg 677Trp 677Arg 753Gln 753Arg 677Trp 677Arg
Man 5 41 0 46 0 58 0 58
Woman 4 36 0 40 0 56 0 56
Total 9 77 0 86 0 114 0 114
of study population are described in Table 1. 
No symptoms were reported in laten TB group, 
because by definition TB laten is a person with 
no sign and symptom of TB and also with no 
radiological appearance of TB but with positive 
tuberculin skin test.
Table 3. Comparison of polymorphism Arg753Gln group 
of pulmonary TB active and latent TB
Genotype Active Pulmonary TB Latent TB Total
Mutants 9 0 9
Wild Type 77 114 191
Note: exact Fisher test, p<0.00. RO: 28.07, CI (95%): 
1.61 to 489.5, p=0.022; Mutants: genotype Arg/Gln, Gln/
Gln; Wild Type:Arg/Arg
Odds ratio for heterozygous mutant 
polymorphism Arg753Gln TLR2 gene for 
active pulmonary TB was 28.07 with 95% CI 
from 1.61 to 489.5 and p=0.022. This wide range 
of confidence interval is probably due to small 
number of Arg753Gln mutant found. Odds ratios 
was calculated by adding 0.5 to each cell because 
the cell (b) was zero.17
Comparison of cytokine levels between 
patients with active pulmonary TB with and 
without Arg753Gln gene polymorphism and 
latent TB were done.
Active pulmonary tuberculosis patients with 
and without polymorphism Arg753Gln gene 
TLR2, and latent TB shows significantly different 
levels in IFN-γ, TNF-α and IL-10 serum level, 
but not IL-12 level (Table 4).
Further analysis showed that there were 
no significant differences in levels of IFN-γ, 
TNF-α, IL-10 and IL-12 serum between active 
pulmonary tuberculosis with polymorphism 
Arg753Gln and active pulmonary tuberculosis 
patients without this polymorphism (Table 5).
Distribution of Arg753Gln and Arg677Trp 
polymorphism TLR2 Gene
Heterozygote Arg753Gln Polymorphisms 
of gene TLR2 was found in 9 (10.5%) cases 
consisted of 5 (5.8%) male and 4 (4.7%) 
female, but none in the latent TB group and no 
homozygote polymorphism was found. There 
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DISCUSSION
This was the first study in Indonesia about the 
existence and role of Arg677Trp and Arg753Gln 
polymorphism in toll-like receptor (TLR) 2 gene 
in pulmonary TB. Polymorphisms of genes 
varies and strongly depends on the ethnicity 
and geography.7,12,16,18 Kang19 showed close 
relationship between polymorphisms Arg677Trp 
TLR2 gene and diseases caused by mycobacteria. 
A study in Korea showed that polymorphism 
was found in 22% of patients with lepromatous 
leprosy but not found in lepromatous tuberculoid 
and healthy subjects. Ryu20 in Korea studied 
non-tuberculosis mycobacteria (NTM) and 
healthy controls and did not find Arg753Gln 
and Arg677Trp polymorphisms. Yoon et al.21 
in Korea also did not find these TLR2 gene 
polymorphism, both in 154 patients with 
bacteremia and in 179 controls.
In Tunisia, Arg677Trp polymorphism 
Table 4. Differences in cytokines level active TB wild type and mutant alleles with latent TB
Variables
Active Pulmonary TB Latent TB







 - X (SD) 12.33 (7.99) 16.02 (10.28) 1.04 (1.57) 53.361 <0.001
 - median (range) 13.2 (1.21 to 28.0) 11.6 (2.56 to 31.52) 0.53 (0.06 to 8.37)
TNF-α
 - X (SD) 6.72 (6.05) 5.33 (2.97) 1.87 (0.76) 52.215 <0.001
 - median (range) 5.6 (1.97 to 34.84) 4.44 (2.35 to 11.81) 1.65 (0.95 to 5.52)
IL-10
 - X (SD) 0.98 (2.29) 0.51 (0.43) 0.21 (0.09) 24.418 <0.001
 - median (range) 0.30 (0.13 to 12.73) 0.34 (0.13 to 1.48) 0.02 (0.09 to 0.55)
IL-12
 - X (SD) 0.41 (0.12) 0.42 (0.08) 0.41 (0.11) 0.556 0.757
 - median (range) 0.38 (0.24 to 0.71) 0.46 (0.28 to 0.50) 0.39 (0.25 to 0.76)
X2KW= Kruskal Wallis
Table 5. Differences in cytokine levels between patients with active pulmonary TB Arg753Gln Gene Polymorphism of 
TLR2 and pulmonary TB patients without Polymorphism
Variables
Active Pulmonary TB





 - X (SD) 12.33 (7.99) 16.02 (10.28) 0.891 0.388
 - median (range) 13.2 (1.21 to 28.0) 11.6 (2.56 to 31.52)
TNF-α
 - X (SD) 6.72 (6.05) 5.33 (2.97) 0.437 0.679
 - median (range) 5.6 (1.97 to 34.84) 4.44 (2.35 to 11.81)
IL-10
 - X (SD) 0.98 (2.29) 0.51 (0.43) 0.130 0.899
 - median (range) 0.30 (0.13 to 12.73) 0.34 (0.13 to 1.48)
IL-12
 - X (SD) 0.41 (0.12) 0.42 (0.08) 0.746 0.463
 - median (range) 0.38 (0.24 to 0.71) 0.46 (0.28 to 0.50)
ZMW= Mann-Whitney
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was found to be associated with TB disease. 
This polymorphism was found in 31 of 33 
(94%) of TB patients compared with 10 of 33 
(34%) healthy controls.12 In native Germany, 
Arg677Trp polymorphism was not found at 
all, but Arg753Gln polymorphism was found 
9.4%.22 In healthy Turkish people, Arg753Gln 
polymorphism was found in 10.34% and 12.3%23 
while Arg677Trp was not found. Lorenz et al.6 
found Arg753Gln polymorphism in 3% of the 
Caucasian population.
Association between TB and Arg753Gln 
polymorphism clearly demonstrated by Ogus et 
al.7 in Turkey. This study involved 151 newly 
diagnosed TB patients and 116 healthy control. 
Arg753Gln polymorphism was found in 17.9% 
of patients with TB and 7.7% in controls with 
an increased risk for tuberculosis by 6.35 times 
for homozygous polymorphism Arg753Gln and 
1.60 times for subjects with heterozygous. In 
meta-analysis of 7 studies which also include 
the above study, Wu24 in 2015 provide evidence 
that TLR2 gene Arg753Gln polymorphism is a 
risk factor of TB (OR 3.17, 95% CI: 2.31 – 4.35).
Biswas et al.18 in India did not find Arg753Gln 
and Arg677Trp polymorphisms at 100 TB cases 
and 100 healthy controls. In contrast, Mishra 
et al9 also in India, found the prevalence of 
homozygous mutant Arg753Gln TLR2 gene 
polymorphism was 5%. This finding emphasized 
the importance of geographical factor because 
their ethnicity were the same.
At 170 TB patients and 199 controls 
Zhejiang Han Chinese population, heterozygous 
polymorphisms Arg753Gln TLR2 gene was 
found in 41.77% of cases and in 15.8% of healthy 
controls, all in heterozygous form.8 Xue et al25 in 
Chinese population failed to find a relationship 
Arg753Gln and Arg677Trp gene polymorphisms 
TLR2 with tuberculosis. A study in Iran also 
did not found association between Arg677Trp 
polymorphism and tuberculosis.26 A study in 
Sudan also did not found association between 
Arg753Gln with susceptibility to MTb.27
Our study, the first in Indonesia, found the 
prevalence of polymorphisms of TLR2 gene 
Arg753Gln in 10.5% of patients with active 
pulmonary tuberculosis but did not found 
Arg677Trp polymorphism TLR2 gene. This 
study showed association between Arg753Gln 
polymorphism of TLR2 gene and active 
pulmonary TB disease (p<0.001) with Odds 
Ratio of 28.07 times in person with Arg753Gln 
polymorphism of TLR2 gene. By using the 
formula p = RO / (1 + RO), then the probability 
of a person with a polymorphism in the gene TLR 
Arg753Gln to have pulmonary tuberculosis is 
96.6%. The difference with other similar studies 
is that in this study, we use latent TB as control 
to ensure exposure to MTb in both study groups. 
Although our study population for Arg677Trp 
Gene TLR2 polymorphism is sufficient but we 
did not found this polymorphism. This reflects 
that Arg677Trp TLR2 gene was not a risk factor 
for active pulmonary tuberculosis in Indonesia. 
The weakness of this study was the amount of 
study population in Arg753Gln Polymorphism 
TLR2 gene which didn’t reach minimal sample 
calculated, although we still found Arg753Gln 
polymorphism TLR2 gene in this study.
No difference was found in serum cytokines 
among active pulmonary tuberculosis patients with 
and without polymorphisms of genes Arg753Gln 
TLR2 suggesting that increased susceptibility to 
TB in the TLR2 gene polymorphism Arg753Gln 
did not caused by changes in cytokine levels. 
There are several possible explanations. Firstly, 
Arg753Gln polymorphisms in TLR2 gene disrupt 
the process of phagocytosis by macrophages 
and intramacrophage killing but do not alter 
cytokines production. Secondly, the production 
of cytokines (IFN-γ, TNF-α, IL-10 and IL-12) 
is not merely through TLR2 signaling pathway. 
Aravalli et al28 showed that mortality did 
not increase in mice with TLR2 - / - when 
infected with HSV; and the chemokine CXCL10 
production was not affected by TLR2 signaling. 
Beijing genotype was turned out to stimulate the 
production of cytokines IL-6, TNF-α, IL-10, and 
GRO-α lower than wild strain H37Rv MTb. This 
study does not rule out the possibility of MTb 
genotype role.29 Other possible explanation of the 
susceptibility mechanisms is that polymorphism 
of TLR2 gene control the expansion of NK 
cells.30
Therefore, it is necessary to do further 
studies to prove these allegations. These 
studies include association between TLR and 
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Vitamin D level, also with natural resistance-
associated macrophage protein (Nramp) gene 
that important in activation of macrophages and 
intramacrophage killing. It is also necessary 
to uncovered the association betweenn TLR2 
with intramacrophage effectors such as reactive 
oxygen intermediate and reactive nitrogen 
intermediate.5,31
CONCLUSION
Arg753Gln TLR2 gene polymorphism is a 
risk factor for active pulmonary TB in Indonesian 
population, in Bandung but not Arg677Trp 
polymorphism. This increased risk of active 
pulmonary TB disease in subjects with TLR2 
gene Arg753Gln polymorphism is not associated 
with changes in the levels of IFN-γ, TNF-α, IL-
10 and IL-12 serum.
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